1832 Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5
Closed -$1.28K 840
2023
Q3
$1.28K Buy
+5
New +$1.34K ﹤0.01% 824
2022
Q4
Sell
-35,700
Closed -$9.53M 897
2022
Q3
$9.53M Buy
+35,700
New +$7.58M 0.02% 371
2022
Q2
Sell
-10
Closed -$2K 865
2022
Q1
$2K Hold
10
﹤0.01% 913
2021
Q4
$2K Sell
10
-1,082
-99% -$278K ﹤0.01% 690
2021
Q3
$314K Buy
+1,092
New +$358K ﹤0.01% 607
2020
Q2
Sell
-43,700
Closed -$13.9M 655
2020
Q1
$13.9M Buy
+43,700
New +$13.3M 0.05% 204
2019
Q3
Sell
-4,500
Closed -$1.08M 670
2019
Q2
$1.08M Buy
4,500
+4,473
+16,567% +$1.03M ﹤0.01% 456
2019
Q1
$6K Buy
27
+22
+440% +$6.93K ﹤0.01% 589
2018
Q4
$2K Sell
5
-32,626
-100% -$10.4M ﹤0.01% 607
2018
Q3
$11.4M Buy
32,631
+12,771
+64% +$4.4M 0.04% 220
2018
Q2
$5.74M Sell
19,860
-31,874
-62% -$8.96M 0.02% 281
2018
Q1
$14M Sell
51,734
-10,966
-17% -$3.4M 0.05% 202
2017
Q4
$19.8M Sell
62,700
-101,186
-62% -$32.5M 0.06% 185
2017
Q3
$49.7M Buy
163,886
+26,886
+20% +$7.96M 0.17% 113
2017
Q2
$37.2M Buy
137,000
+18,400
+16% +$4.87M 0.17% 133
2017
Q1
$32.5M Sell
118,600
-223,320
-65% -$63.1M 0.12% 162
2016
Q4
$101M Buy
341,920
+165,600
+94% +$49.1M 0.17% 131
2016
Q3
$55.2M Sell
176,320
-22,680
-11% -$6.72M 0.21% 111
2016
Q2
$48.4M Buy
199,000
+5,980
+3% +$1.58M 0.19% 118
2016
Q1
$82.6M Sell
193,020
-4,780
-2% -$1.26M 0.2% 118
2015
Q4
$61.2M Buy
197,800
+25,460
+15% +$7.32M 0.26% 96
2015
Q3
$50.5M Sell
172,340
-34,449
-17% -$11.4M 0.21% 106
2015
Q2
$83.4M Sell
206,789
-223,132
-52% -$89.5M 0.28% 85
2015
Q1
$180M Buy
429,921
+263,920
+159% +$104M 0.68% 41
2014
Q4
$56.3M Sell
166,001
-295,880
-64% -$95.7M 0.17% 122
2014
Q3
$152M Buy
461,881
+50,366
+12% +$16.6M 0.5% 53
2014
Q2
$129M Buy
411,515
+189,815
+86% +$57.1M 0.41% 63
2014
Q1
$64.4M Buy
+221,700
New +$70.4M 0.22% 111

Other funds holding BIIB